Minimum Investment
—
Price Range
0.00
Lot Size
0 shares
Issue Size
₹2,180 Cr
About the Company
Incorporated in 2002, Symbiotec Pharmalab Ltd. is a pharmaceutical and biotechnology company engaged in the development and manufacturing of active pharmaceutical ingredients, nutritional ingredients, and specialty products. The company caters to domestic and international markets across regulated and emerging regions.
Bookbuilding IPO
IPO Objectives
- Prepayment and/or repayment, in full or in part, of all or a portion of certain outstanding borrowings availed by the Company
- General corporate purposes
Important Dates
| Bid/Offer Opens On | 18-08-2026 |
| Bid/Offer Closes On | |
| Finalisation of Basis of Allotment | — |
| Initiation of Refunds | — |
| Credit of Shares to Demat | — |
| IPO Listing Date | — |
Grey Market Premium (GMP)
—
Registrar
MUFG Intime India Pvt.Ltd.
Lead Managers
- JM Financial Ltd. Avendus Capital Pvt.Ltd. Motilal Oswal Investment Advisors Ltd. Nomura Financial Advisory & Securities (India) Pvt.Ltd\r\n\r\n\r\n
Company Promoters
- Anil Satwani
- Kashish Satwani
- Sushil Satwani and Satwani Holdings LLP.
